Actinium Pharmaceuticals, Inc. (ATNM)
Retained Earnings
-$387.33M
Quarterly · Period ending: · USD
ATNM Retained Earnings
Latest reported-$387.33Mperiod ending
Latest reported-$387.33Mperiod ending
ATNM Quarterly Retained Earnings (-$193.84K → -$387.33M)
Quarterly retained earnings
High-resolution chart · PNG
ATNM retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -387,334,000 | |
| -415,235,000 | |
| -409,713,000 | |
| -403,773,000 | |
| -398,642,000 | |
| -391,764,000 | |
| -375,826,000 | |
| -369,174,000 | |
| -357,606,000 | |
| -346,253,000 | |
| -337,583,000 | |
| -328,259,000 | |
| -314,983,000 | |
| -299,802,000 | |
| -288,765,000 | |
| -278,118,000 | |
| -268,644,000 | |
| -260,877,000 | |
| -255,748,000 | |
| -247,738,000 | |
| -241,315,000 | |
| -236,294,000 | |
| -230,974,000 | |
| -224,594,000 | |
| -219,054,000 | |
| -214,428,000 | |
| -208,758,000 | |
| -204,155,126 | |
| -197,555,800 | |
| -192,527,613 | |
| -186,857,238 | |
| -180,537,491 | |
| -174,389,402 | |
| -169,467,298 | |
| -163,153,037 | |
| -157,989,966 | |
| -151,667,093 | |
| -144,613,385 | |
| -136,551,802 | |
| -129,856,115 | |
| -123,257,462 | |
| -116,633,376 | |
| -112,230,078 | |
| -105,689,556 | |
| -101,743,362 | |
| -94,279,627 | |
| -91,204,764 | |
| -85,778,681 | |
| -79,701,657 | |
| -83,216,752 | |
| -66,517,255 | |
| -60,637,414 | |
| -59,216,501 | |
| -56,432,490 | |
| -55,743,463 | |
| -279,428 | |
| -275,711 | |
| -269,392 | |
| -259,764 | |
| -257,117 | |
| -253,603 | |
| -274,058 | |
| -270,053 | |
| -261,531 | |
| -251,852 | |
| -280,023 | |
| -271,727 | |
| -262,229 | |
| -258,380 | |
| -254,709 | |
| -249,396 | |
| -241,784 | |
| -238,454 | |
| -228,980 | |
| -208,639 | |
| -204,002 | |
| -197,649 | |
| -193,839 | |
| -193,839 |